Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7222901 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL10936953 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL6742265 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL7218993 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL7219194 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL42508 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL7217255 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL7218971 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL3454037 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 | |
| SCHEMBL3671730 | 1.00 | CA2 (0.58) | CA2CA1NAAAEPHX1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053119-B1 | Fabric softening compositions having improved stability upon storage | PROCTER & GAMBLE (US) | 2016-09-07 | — | — | EP | claimed |
| US-20090111728-A1 | Fabric Softening Compositions Having Improved Stability Upon Storage | THE PROCTER & GAMBLE COMPANY | 2009-04-30 | — | — | US | claimed |
| WO-2009053877-A2 | FABRIC SOFTENING COMPOSITIONS HAVING IMPROVED STABILITY UPON STORAGE | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-30 | — | — | WO | claimed |
| EP-2053119-A1 | Fabric softening compositions having improved stability upon storage | The Procter and Gamble Company (US) | 2009-04-29 | — | — | EP | claimed |
| EP-1149888-A1 | Application of fatty acidesters as illuminating oil | Cognis Deutschland GmbH (DE) | 2001-10-31 | — | — | EP | claimed |
| EP-3941199-A1 | STABILIZED THIOKETONE FORMULATIONS | Bayer Aktiengesellschaft (DE) | 2022-01-26 | — | — | EP | disclosed |
| WO-2020187871-A1 | STABILIZED THIOKETONE FORMULATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-09-24 | — | — | WO | disclosed |
| CN-104684538-B | Cosmetic or dermatological composition for moisturizing the skin | 莱雅公司 | 2017-07-21 | — | — | CN | disclosed |
| EP-2053119-B1 | Fabric softening compositions having improved stability upon storage | PROCTER & GAMBLE (US) | 2016-09-07 | — | — | EP | disclosed |
| US-7858575-B2 | Fabric softening compositions comprising glycerol tricaprylate having improved stability upon storage | THE PROCTER & GAMBLE COMPANY (US) | 2010-12-28 | — | — | US | disclosed |
| US-20090111728-A1 | Fabric Softening Compositions Having Improved Stability Upon Storage | THE PROCTER & GAMBLE COMPANY | 2009-04-30 | — | — | US | disclosed |
| WO-2009053877-A2 | FABRIC SOFTENING COMPOSITIONS HAVING IMPROVED STABILITY UPON STORAGE | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-30 | — | — | WO | disclosed |
| EP-2053119-A1 | Fabric softening compositions having improved stability upon storage | The Procter and Gamble Company (US) | 2009-04-29 | — | — | EP | disclosed |
| US-7255870-B2 | Composition containing a semicrystalline polymer, uses thereof, and method for making | L'OREAL (FR) | 2007-08-14 | — | — | US | disclosed |
| US-6667285-B1 | Branched-chain carboxylic acid monoalkyl ester with outstanding hydrolytic stability | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030165451-A1 | Composition containing a semicrystalline polymer, uses thereof, and method for making | L'OREAL (FR) | 2003-09-04 | — | — | US | disclosed |
| EP-1225213-A1 | LUBRICATING OIL FOR REFRIGERATOR, HYDRAULIC FLUID COMPOSITION FOR REFRIGERATOR AND METHOD FOR LUBRICATION OF REFRIGERATOR | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-1149888-A1 | Application of fatty acidesters as illuminating oil | Cognis Deutschland GmbH (DE) | 2001-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165451-A1 | Composition containing a semicrystalline polymer, uses thereof, and method for making | CUTA, POLB, LRBA | CA2 4226/4885CA1 4067/4885NAAA 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.